Skip to main content
. Author manuscript; available in PMC: 2016 Apr 18.
Published in final edited form as: Am J Hum Biol. 2013 May 4;25(4):465–472. doi: 10.1002/ajhb.22381

TABLE 2.

Phenotypic, genetic, and environmental correlations between adult height and lipid profilea

Males Females


rP rA (CI) rE (CI) rP rA (CI) rE (CI)
Serum lipids
Total-C −0.18c −0.21 (−0.38,−0.05) 0.13 (−0.15,0.40) −0.07 −0.12 (−0.28,0.04) 0.03 (−0.19,0.24)
HDL-C −0.12 −0.12 (−0.28,0.03) 0.17 (−0.10,0.43) 0.03 0.00 (−0.15,0.16) 0.04 (−0.18,0.26)
LDL-C −0.17c −0.18 (−0.33,−0.01) −0.02 (−0.30,0.26) −0.11b −0.17 (−0.32,−0.01) −0.02 (−0.24,0.20)
HDL-C/LDL-C 0.07 0.06 (−0.09,0.22) 0.13 (−0.15,0.39) 0.11b 0.13 (−0.02,0.28) 0.04 (−0.18,0.26)
IDL-C −0.18c −0.21 (−0.38,−0.04) 0.10 (−0.19,0.38) −0.12b −0.19 (−0.34,−0.03) 0.05 (−0.18,0.26)
Triglycerides −0.03 −0.04 (−0.21,0.12) −0.05 (−0.33,0.23) −0.06 −0.11 (−0.27,0.05) 0.02 (−0.20,0.23)
Lipoprotein particle size
HDL particle size −0.05 −0.05 (−0.21,0.11) 0.10 (−0.18,0.36) 0.07 0.06 (−0.09,0.20) −0.02 (−0.24,0.20)
LDL particle size −0.01 −0.06 (−0.31,0.16) 0.08 (−0.21,0.35) −0.07 −0.11 (−0.29,0.08) 0.05 (−0.17,0.25)
VLDL particle size 0.06 0.07 (−0.10,0.25) −0.04 (−0.31,0.24) 0.03 0.02 (−0.15,0.19) 0.05 (−0.16,0.27)
HDL particle concentration
Small HDL −0.13b −0.15 (−0.33,0.02) 0.14 (−0.17,0.42) −0.07 −0.12 (−0.28,0.04) 0.07 (−0.15,0.28)
Medium HDL −0.15b −0.21 (−0.38,−0.04) 0.17 (−0.11,0.42) −0.06 −0.13 (−0.29,0.04) 0.11 (−0.11,0.32)
Large HDL −0.09 −0.09 (−0.25,0.07) 0.08 (−0.20,0.34) 0.04 0.02 (−0.14,0.17) 0.02 (−0.20,0.24)
Total HDL −0.14b −0.17 (−0.33,−0.01) 0.19 (−0.09,0.44) −0.01 −0.06 (−0.22,0.10) −0.06 (−0.16,0.27)
LDL particle concentration
Small LDL −0.17c −0.18 (−0.33,−0.02) −0.01 (−0.28,0.27) −0.10 −0.16 (−0.32,0.00) −0.02 (−0.24,0.20)
Medium LDL −0.17c −0.17 (−0.33,−0.01) −0.03 (−0.31,0.25) −0.11b −0.17 (−0.32, −0.01) −0.03 (−0.25,0.19)
Large LDL −0.19c −0.21 (−0.36,−0.05) 0.03 (−0.25,0.31) −0.13c −0.21 (−0.36, −0.05) 0.00 (−0.22,0.22)
Total LDL −0.18c −0.19 (−0.35,−0.04) 0.00 (−0.28,0.28) −0.12b −0.19 (−0.34, −0.03) −0.01 (−0.23,0.21)
VLDL particle concentration
Small VLDL −0.07 −0.11 (−0.27,0.05) −0.02 (−0.30,0.26) −0.10 −0.15 (−0.31,0.01) 0.01 (−0.21,0.23)
Medium VLDL 0.01 −0.00 (−0.17,0.17) −0.05 (−0.32,0.23) −0.03 −0.06 (−0.23,0.11) 0.06 (−0.16,0.27)
Large VLDL 0.03 0.03 (−0.16,0.23) −0.02 (−0.40,0.38) −0.03 −0.08 (−0.26,0.10) 0.06 (−0.17,0.29)
Total VLDL −0.04 −0.07 (−0.23,0.09) −0.02 (−0.30,0.26) −0.08 −0.12 (−0.28,0.04) 0.02 (−0.20,0.24)
Apolipoproteins
Apolipoprotein A1 −0.17c −0.20 (−0.36,−0.04) 0.16 (−0.11,0.42) 0.02 −0.00 (−0.18,0.18) 0.00 (−0.24,0.24)
Apolipoprotein B −0.09 −0.12 (−0.28,0.04) 0.08 (−0.20,0.36) −0.09 −0.11 (−0.27,0.05) −0.02 (−0.25,0.22)
ApoB/ApoA-1 0.01 −0.01 (−0.16,0.15) −0.03 (−0.31,0.24) −0.11 −0.11 (−0.26,0.05) −0.03 (−0.26,0.21)
a

Phenotypic correlations (rP) were estimated using Pearson’s correlation method. Genetic (rA) and environmental (rE) correlations between height and each of the analyzed lipids and lipoproteins were obtained from the multivariate Cholesky model, which decomposes phenotypic covariation into uncorrelated genetic and environmental factors. In each multivariate model, five phenotypes were included: height at 11–12, 14, and 17 years and young adulthood, and one lipoprotein. CI, 95% confidence interval for rA and rE.

b

P<0.05

c

P<0.01.